Pakistan Establishment Licence: The Prerequisite for Product Registration Applications

1. Key takeaways

Without a valid Establishment Licence, a product enlistment or registration application will not be accepted in Pakistan. Rule 14(1) of the Medical Devices Rules, 2017 restricts who may apply to exactly two categories of entities: an establishment holding a valid manufacturing licence, or an importer holding a valid establishment licence who acts in the capacity of an authorised representative. This means the Establishment Licence is a prerequisite for product submission, not a parallel administrative formality that can be completed alongside the product dossier.

• The Establishment Licence sits at the entry point of the entire Pakistan regulatory pathway, and no product application moves forward until it is in place and valid.
• Rule 14(1) is deliberately narrow: only licensed establishments and licensed importers acting as authorised representatives may file, so foreign sponsors must secure the licence through a qualifying local partner before anything else.
• The licence and the product dossier are two separate milestones that cannot substitute for each other, although the preparation work behind both can and should run in parallel on the same project calendar.
• Because the licence is a statutory gate written into the Medical Devices Rules, 2017, planning it after the dossier is finished will simply leave a completed submission waiting with no channel through which it can be filed.
• The licence carries a 5-year validity period, so entity qualification is not a one-time event but a recurring obligation that must be diaried and renewed on time.

2. Legal basis

The applicant-eligibility rules, the decision-making authority for enlistment and registration, and the procedure and fees for the Establishment Licence are all anchored in a single instrument: the Medical Devices Rules, 2017, which were notified on 16 January 2018. Because everything hangs off one rulebook, the sequencing argument is easy to make to stakeholders — the same text that defines who may apply also defines who decides and what it costs. The table below summarises the specific provisions that matter for the licence-first sequencing described in this guide.

3. Expert insights

Insight one: this is the design feature that most sharply distinguishes Pakistan from most other Asian markets. In India, the import licence (MD-15) and the registration (MD-14) are linked but can be understood as separate steps; in Bangladesh, the establishment permission and product registration also sit in different sequences. Pakistan’s rules write the Establishment Licence directly into the applicant-eligibility clause, which turns it into a hard gate rather than an administrative convenience.

Insight two: placing the Establishment Licence first effectively splits the compliance workload into two milestones. The first milestone asks whether the entity itself is qualified to act (the Establishment Licence); the second asks whether the product may be sold (enlistment or registration). The two milestones cannot replace each other, but the preparation work behind them can proceed in parallel on the calendar. Teams that treat them as one merged project usually discover, at submission time, that the licence track was the one carrying the real delay. Conversely, sponsors who sequence the licence first and keep the dossier work running alongside rarely lose any calendar time at all, because the licence processing window is absorbed by the dossier preparation that would be happening anyway.

Insight three: the Establishment Licence has a 5-year validity period and must be renewed. Registration practice compilation shows that both the Establishment Licence and the product enlistment or registration carry a validity of 5 years, and renewal, like the original application, can only be processed through the online portal (from 21 July 2025 onward). Renewal is therefore not a paper exercise either: the same digital-channel rule that governs new applications governs renewals, and a lapse in the licence during the renewal window would put every dependent product authorisation at risk of standing on an expired eligibility foundation. For multi-product portfolios this compounds quickly — one expired licence can freeze an entire Pakistani product line until the entity qualification milestone is restored.

4. Practical recommendations

In practice, the most common failure pattern GRZAN sees in Pakistan projects is a sponsor who finishes a technically excellent dossier and then discovers that the local partner named in the application either has no Establishment Licence or holds one that is about to expire. Everything below follows from avoiding that single mistake: confirm the entity milestone before committing resources to the product milestone, and keep both moving together.

• At project kick-off, verify immediately whether the client’s chosen local partner holds a valid Establishment Licence, and record exactly when that licence expires.
• If the partner does not yet hold the licence, place the Establishment Licence application at the very front of the project plan, ahead of any product dossier submission.
• Run dossier preparation and the FSC certification chain in parallel with the licence track, so the product submission never sits idle for months waiting for eligibility to be established.
• Treat the two milestones — entity qualification and product authorisation — as separately tracked workstreams with their own calendars and their own verification points.
• Diary the 5-year validity of the Establishment Licence and the online renewal requirement into the compliance calendar at the moment the licence is granted, not years later.

5. Verification checklist

• □ Confirmed that the local partner holds a valid Establishment Licence
• □ Checked the licence expiry date and entered it into the renewal calendar
• □ The Establishment Licence track has been scheduled ahead of the product submission
• □ Dossier preparation and the FSC certification chain have been started in parallel
• □ The team is aware that the Establishment Licence is valid for 5 years
• □ The team is aware that renewal must also be handled online

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Pakistan. Our team prepares dossiers to DRAP expectations, manages eCTD-format submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com